There is a fundamental difference between two types of artificial intelligence that look the same on the surface to the lay user: both answer questions in natural language, both appear confident in their answers, and both produce coherent, well-written text. But they are radically different in what they do internally, how they were trained, and what kind of trust they deserve in a clinical context.
The first type is clinical medical AI systems: algorithms specifically trained with validated clinical data, evaluated in rigorous clinical trials, integrated into hospital workflows with permanent medical supervision, and subject to strict health regulation before being authorized. There are more than 900 algorithms with FDA approval and more than 200 with EMA authorization. They detect cancer in medical images. They predict sepsis hours in advance. They identify dangerous drug interactions before the doctor confirms the prescription.
The second type is general-purpose generative language models: ChatGPT, Claude, Gemini, Copilot. They were designed to produce coherent and useful text from large volumes of information. They are extraordinarily capable of many tasks. But in the medical context they have critical limitations that make them inadequate to make diagnostic decisions: they do not verify the veracity of the information they generate, when they make mistakes they do so in a way that is convincing and difficult to detect, and they do not know the specific clinical history of the patient who is asking them.
The problem of overconfidence
The Cigna International Health study found that 44% of Spaniards consider the impact of AI on healthcare to be positive. That's a reasonable number that reflects a healthy openness to technology. The problem arises when that positive attitude translates into trusting the responses of a generative chatbot as if they were the equivalent of a medical consultation. Doctors from Osakidetza, the Basque health system, published a specific warning about this risk in May 2026, noting that some people interpret the responses of these tools as conclusive diagnoses and act accordingly without consulting a health professional.
Medical AI vs. Generative chatbot — The differences that matter
- Clinical medical AI: trained with validated clinical data, evaluated in trials, supervised by doctors
- Generative chatbot: trained to produce coherent text, not for medical diagnosis
- Clinical AI: hyper-specialized in one area, regulated before use
- Chatbot: generalist, not validated for diagnosis, can "hallucinate" with apparent safety
- Proper use of chatbots in health: understand already established diagnoses, prepare questions for consultation
- Inappropriate use: diagnosis of new symptoms, medication decisions, test interpretation
Self-medication driven by digital search
The trend is not just a problem with AI chatbots: searching for symptoms on the internet has been generating a pattern of self-medication for years that experts consider worrying. The difference that generative AI introduces is quantitative and qualitative: quantitative because the accessibility and apparent quality of the responses massively increases the number of people who use them; qualitative because the answers from a sophisticated chatbot are incomparably more convincing than a Google search result.
The correct use of these tools in health exists and has real value. A generative chatbot can be useful for understanding information a doctor has already given, for translating complex clinical terms into more accessible language, for preparing relevant questions before a consultation, or for general guidance on health habits. What it cannot do—and what some users expect it to do—is replace the assessment of a professional who knows the patient's history, who can perform a physical examination, and who has the training to interpret the set of symptoms in that person's specific context.
Share this article
